Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
16.77
+0.82 (5.14%)
At close: Jul 2, 2026, 4:00 PM EDT
16.85
+0.08 (0.47%)
After-hours: Jul 2, 2026, 7:46 PM EDT
Takeda Pharmaceutical Company Employees
Takeda Pharmaceutical Company had 47,029 employees as of March 31, 2026. The number of employees decreased by 426 or -0.90% compared to the previous year.
Employees
47,029
Change (1Y)
-426
Growth (1Y)
-0.90%
Revenue / Employee
$602,542
Profits / Employee
-$20,379
Market Cap
52.50B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 47,029 | -426 | -0.90% |
| Mar 31, 2025 | 47,455 | -1,826 | -3.71% |
| Mar 31, 2024 | 49,281 | 186 | 0.38% |
| Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
| Mar 31, 2022 | 47,347 | 248 | 0.53% |
| Mar 31, 2021 | 47,099 | -396 | -0.83% |
| Mar 31, 2020 | 47,495 | -2,083 | -4.20% |
| Mar 31, 2019 | 49,578 | 22,348 | 82.07% |
| Mar 31, 2018 | 27,230 | -2,670 | -8.93% |
| Mar 31, 2017 | 29,900 | -1,268 | -4.07% |
| Mar 31, 2016 | 31,168 | -160 | -0.51% |
| Mar 31, 2015 | 31,328 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 33,950 |
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,527 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
TAK News
- 2 days ago - Takeda Pharmaceutical Co Ltd (TAK) Stock Up 5.1% but GF Value Says Overvalued -- GF Score: 77/100 - GuruFocus
- 3 days ago - Insilico Medicine Announces Strategic AI Drug Discovery Collaboration With Takeda - Nasdaq
- 3 days ago - Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery - PRNewsWire
- 3 days ago - Takeda, InSilico Strike AI Drug-Discovery Deal Worth Up to $600 Million - WSJ
- 10 days ago - Takeda Appoints Julie Kim President & CEO Following 18-Month Transition As Weber Retires - Nasdaq
- 11 days ago - Takeda CEO Christophe Weber retires, Julie Kim succeeds - TheFly
- 11 days ago - Takeda Names Julie Kim CEO As Christophe Weber Retires - Nasdaq
- 11 days ago - Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO - Business Wire